EP3167888
TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.3.2007EP published:
1.5.2024EP application number:
16195355.9
EP translation filed:
24.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
14.3.2027Expiry date:
14.3.2027
Title in English:
TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENTLanguage of the patent:
English
Timeline
Today
15.3.2007EP application
1.5.2024EP Publication
24.5.2024Translation submitted
15.6.2024Registration published
14.3.2027Expires
Owner
Name:
Alexion Pharmaceuticals, Inc.Address:
100 College Street, New Haven, CT 06510, US
Inventor
Name:
BELL, LeonardAddress:
Woodbridge, CT Connecticut 06525, US
Name:
ROTHER, Russell P.Address:
Oklahoma City, OK Oklahoma 73151, US
Name:
EVANS, Mark J.Address:
Radnor, PA, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
783070 PDate:
15.3.2006Country:
US
Classification
Categories:
A61K 31/7105, A61K 38/00, A61K 39/395, A61P 7/06, C07K 16/18, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 19
Paid: 7.3.2025
Expires: 14.3.2026
Payer: Árnason Faktor ehf.
Number: 20
Paid: 20.3.2026
Expires: 14.3.2027
Payer: Árnason Faktor ehf.